CLINICAL_TRIALS
research
· 2025-09-15
Clinical Trial Update: A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed [Phase 3]
Summary
Phase 3 trial update for Beijing Institute of Biological Products' Diphtheria, Tetanus and Acellular Pertussis vaccine adsorbed; the study is currently active b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China National Biotec Group Company Limited | Conditions: Whooping Cough, Diphtheria | Phase 3 | Status: ACTIVE_NOT_RECRUITING